THE SUCCESSFUL APPLICATION OF A HEPARIN NOMOGRAM IN A COMMUNITY-HOSPITAL

被引:18
作者
HOLLINGSWORTH, JA
ROWE, BH
BRISEBOIS, FJ
THOMPSON, PR
FABRIS, LM
机构
[1] SUDBURY GEN HOSP, SHARED PHARM SERV, SUDBURY, ON P3E 3B5, CANADA
[2] SUDBURY GEN HOSP, DEPT INTERNAL MED, SUDBURY, ON, CANADA
[3] SUDBURY GEN HOSP, DEPT EMERGENCY MED, SUDBURY, ON, CANADA
[4] UNIV OTTAWA, SCH MED, NORTHEASTERN ONTARIO FAMILY MED PROGRAM, OTTAWA, ON, CANADA
[5] MEM HOSP, SHARED PHARM SERV, SUDBURY, ON, CANADA
[6] ALGOMA HOSP, SHARED PHARM SERV, SUDBURY, ON, CANADA
[7] ESPANOLA ONTARIO GEN HOSP, ESPANOLA, ON, CANADA
关键词
D O I
10.1001/archinte.155.19.2095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heparin administration by physicians can vary greatly, and this variance can result in ineffective anticoagulation and reduced effectiveness of treatment. Objective: To examine the use of a heparin nomogram in two community hospitals to validate its effect on anticoagulation parameters and to determine its influence on length of hospital stay. Methods: Prenomogram and postnomogram intervention in two community hospitals in Sudbury, Ontario. All patients who presented and were admitted to the hospitals between 1991 and 1994 with a confirmed primary diagnosis of deep vein thrombosis and/or pulmonary embolism were eligible for the study. A heparin nomogram was instituted in April 1993 for treatment of deep vein thrombophlebitis and pulmonary embolism in hospitalized patients. The study patients were designated as prenomogram or postnomogram. Anticoagulation parameters (time to therapeutic activated partial thromboplastin time), number of diagnostic tests, percentage of times within the therapeutic range, and length of hospital stay were recorded for both groups. Results: A total of 326 patients were identified from the database; 163 (50%) met the inclusion criteria. Patients in both groups appeared to be similar. Adequate anticoagulation was achieved faster (17.9 hours postnomogram vs 48.8 hours prenomogram; P<.001) and remained subtherapeutic less frequently in the postnomogram group (number of activated partial thromboplastin time tests below the therapeutic window; 56% prenomogram vs 28% postnomogram; P<.001). There were no differences between the groups with respect to length of stay (11.3 days prenomogram vs 10.9 days postnomogram; P=.60). More activated partial thromboplastin time tests were ordered in the postnomogram group (15.6 postnomogram vs 12.7 prenomogram; P=.001); however, fewer prothrombin time tests were ordered in the postnomogram group. Conclusions: A heparin nomogram was successfully used in a community hospital without a structured hematology-thrombosis service. Therapeutic anticoagulation was achieved faster and maintained more frequently, with less logistical problems, with this protocol. However, additional measures may be required to reduce the length of hospital stay.
引用
收藏
页码:2095 / 2100
页数:6
相关论文
共 14 条
[1]   A STANDARD HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY [J].
CRUICKSHANK, MK ;
LEVINE, MN ;
HIRSH, J ;
ROBERTS, R ;
SIGUENZA, M .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (02) :333-337
[2]   USE OF A STANDARDIZED HEPARIN NOMOGRAM TO ACHIEVE THERAPEUTIC ANTICOAGULATION AFTER THROMBOLYTIC THERAPY IN MYOCARDIAL-INFARCTION [J].
FLAKER, GC ;
BARTOLOZZI, J ;
DAVIS, V ;
MCCABE, C ;
CANNON, CP .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) :1492-1496
[3]  
HAYNES RB, 1990, ANN INTERN MED, V113, P724, DOI 10.7326/0003-4819-113-9-724
[4]   HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].
HIRSH, J ;
VANAKEN, WG ;
GALLUS, AS ;
DOLLERY, CT ;
CADE, JF ;
YUNG, WL .
CIRCULATION, 1976, 53 (04) :691-695
[5]  
HIRSH J, 1991, NEW ENGL J MED, V324, P1565
[6]   ORAL ANTICOAGULANTS - MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE [J].
HIRSH, J ;
DALEN, JE ;
DEYKIN, D ;
POLLER, L .
CHEST, 1992, 102 (04) :S312-S326
[7]   HEPARIN FOR 5 DAYS AS COMPARED WITH 10 DAYS IN THE INITIAL TREATMENT OF PROXIMAL VENOUS THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
ROSENBLOOM, D ;
PANJU, AA ;
BRILLEDWARDS, P ;
GINSBERG, JS ;
HIRSH, J ;
MARTIN, GJ ;
GREEN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1260-1264
[8]   CONTINUOUS INTRAVENOUS HEPARIN COMPARED WITH INTERMITTENT SUBCUTANEOUS HEPARIN IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
HIRSH, J ;
JAY, RM ;
LECLERC, JR ;
GEERTS, WH ;
ROSENBLOOM, D ;
SACKETT, DL ;
ANDERSON, C ;
HARRISON, L ;
GENT, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (18) :1109-1114
[9]   OPTIMAL THERAPEUTIC LEVEL OF HEPARIN-THERAPY IN PATIENTS WITH VENOUS THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
ROSENBLOOM, D ;
LEMAIRE, J ;
PINEO, GF ;
BAYLIS, B ;
GINSBERG, JS ;
PANJU, AA ;
BRILLEDWARDS, P ;
BRANT, R .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (08) :1589-1595
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481